Benzinga
España
Italia
대한민국
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Benzinga
Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
Prediction Markets
Private Markets
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Markets
Pre-Market
Prediction Markets
Private Markets
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
Zacks
Earnings Season Preview: How Will Corporate Profit Outlooks Impact Markets In 2024?
CrowdStrike Q3 Preview: Can Strong Deals Pipeline Drive Earnings Beat?
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
Partner Content
CrowdStrike Q3 Preview: Can Strong Deals Pipeline Drive Earnings Beat?
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
Partner Content
Zacks Analyst: Take A Look At Food Stocks
Strong Q1 For S&P 500 Companies, But Brace For A Slowdown
Zacks Analyst: Take A Look At Food Stocks
Strong Q1 For S&P 500 Companies, But Brace For A Slowdown
Chicken Wing Prices Still In Bull Market (And So Are Wingstop Investors)
Dividend Strategies To Consider In 2016
Read More...
Zacks Recent News
EXCLUSIVE: Solar Tax Credit To 'Undoubtedly' Spur Demand And Supply, Clean Energy Fuels Could Be Surprise Beneficiary
13 Stocks To Watch In The Healthcare Space
Keep An Eye On These 6 Stocks Monday Morning
Philip Morris Continues Fight Against Anti-Tobacco Crowd
How Post Is Lagging Behind General Mills, Kellogg In Breakfast Wars
How These 5 Beer Companies Have Performed So Far This Year
Barron's Recap: The Penta Quarterly
You'll Never Believe That America's Favorite Coffee Is This Brand
Webster Financial Tanks on Weak Earnings
Zacks Reiterates Outperform Rating, $9.50 PT on POZEN on PA-325/40 Product Data Presentations
UPDATE: Zacks Downgrades Pure Bioscience to Neutral from Outperform on Commercialization Delays
Coffee Makers Spill All Over the Map; Tim Hortons & McDonald's Burnt by Starbucks' Success
Zacks Maintains Outperform, $8.50 PT on Clean Diesel Tech
Power-One Trading Near 52-week Low, Investors Looking to Let Up on Shares
UPDATE: Zacks Initiates FutureFuel at Outperform
Zacks Maintains Outperform on EpiCept
Zacks Maintains Outperform on S&W Seed
Zacks Initiates Coverage of iCAD with Neutral
Zacks Downgrades First Business Financial Services To Neutral, $14.25 PT
CIGNA and Forest Laboratories Open Near 52-Week Highs
Zacks Maintains Neutral Rating On S&W Seed
Zacks Maintains Rating, PT On AMERCO
Bullish on Residential REITs
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started